Accessibility Menu
Mycotopia Therapies logo

Mycotopia Therapies(OTC) TPIA

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-100%
5 Year-100%
1 Year-95%
1 Month-25%
N/A
Mycotopia Therapies last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-28
Mycotopia Therapies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-40%USD 0.002026-08-21
1 month-25%USD 0.002026-07-29
3 month-64.71%USD 0.002026-05-29
Year to date-88%USD 0.002025-12-31
1 year-95.16%USD 0.012025-08-28
3 year-99%USD 0.032023-08-29
5 year-99.98%USD 1.802021-08-27
Since inception-99.99%USD 3.252021-01-21

Mycotopia Therapies Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$2.09M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Dec 31, 2022

TPIA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mycotopia Therapies

Aibotics Inc. is a healthcare company focused on the study of psychedelics for treating mental health issues. Based in Miami, Florida, the company aims to provide innovative methodologies for addressing conditions such as depression, anxiety, and palliative care.

Products and Services
  • Research and development of psychedelic treatments
  • Methodologies for mental health care
  • Focus on palliative care solutions
Growth Outlook
  • Market for psychedelic therapies projected to grow significantly
  • Increased acceptance of alternative mental health treatments
  • Potential partnerships with healthcare providers for expanded reach
Financial Highlights
  • Recent quarterly net income of -$536,968
  • Trailing twelve months (TTM) cash and cash equivalents of $233,427
  • Current ratio of 1.67 indicates good short-term financial health
Aibotics Inc. operates in a rapidly evolving sector, with increasing interest in psychedelic therapies for mental health. The company's focus on innovative treatment methodologies positions it well within this growing market. Despite recent financial challenges, including a net loss in the latest quarter, the current ratio suggests a solid ability to meet short-term obligations. The potential for partnerships and the expanding acceptance of alternative therapies may provide avenues for future growth. Investors may find Aibotics Inc. an intriguing opportunity in the healthcare sector.
AI Generated • Aug 20, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

1

CEO

Benjamin Kaplan

Website

www.aibotics.ai

Headquarters

Aventura, FL 33180, US

TPIA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

50.05%

Return on Capital

N/A

Return on Assets

-380.88%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$1.73M

EBITDA

$95.16K

Operating Cash Flow

-$348.60K

Capital Expenditure

$0.00

Free Cash Flow

-$348.60K

Cash & ST Invst.

$233.43K

Total Debt

$165.00K

Mycotopia Therapies Performance Analysis

Mycotopia Therapies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 2,183N/A
Mycotopia Therapies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A
Mycotopia Therapies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.18-52.8%
20232023-12-31USD -0.08-56.1%
20242024-12-31USD -0.1473.9%
20252025-12-31USD -0.01-91.4%
Mycotopia Therapies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-111.2%
Q42025-12-31-325.9%
Q12026-03-3193.0%
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

1

N/A

Net Income

-$536.97K

-10.5%

EBITDA

-$413.66K

-64.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$233.43K

-3.6%

Total Debt

$165.00K

+0.0%

Accounts Receivable

$0.00

N/A

Inventory

$40.53K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$165.00K

+0.0%

Return on Assets

-3.81%

N/A

Return on Invested Capital

-4.49%

N/A

Free Cash Flow

-$47.02K

+71.4%

Operating Cash Flow

-$47.02K

+71.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QTXBQuantRx Biomedical Corporation
$0.00+400.00%
MRVTMiravant Medical Technologies Inc.
$0.00+29900.00%
POTNPotNetwork Holdings, Inc.
$0.00+0.00%
PPCBPropanc Biopharma, Inc.
$1.35+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About TPIA

What is the current price of Mycotopia Therapies?

Mycotopia Therapies is trading at N/A per share.

What is the 52-week range for Mycotopia Therapies?

Over the past 52 weeks, Mycotopia Therapies has traded between N/A and N/A.

How much debt does Mycotopia Therapies have?

As of the most recent reporting period, Mycotopia Therapies reported total debt of $1.29M.

How much cash does Mycotopia Therapies have on hand?

Mycotopia Therapies reported $233.43K in cash and cash equivalents in its most recent financial results.

What is Mycotopia Therapies’s dividend yield?

Mycotopia Therapies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services